Skip to Main content Skip to Navigation
Journal articles

Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial

Arnaud Pigneux 1 Christian Récher 2, 3, 4 Marie C. Bene Julien Asselineau 5 Ariane C. Mineur Thibaut Leguay 6 Jacques Delaunay 7 Caroline Bonmati 8 Romain Guièze 9 Isabelle Luquet 10 Pascale Cornillet-Lefebvre 10 Catherine Lacombe 11, 12 Jean-Christophe Ianotto 13, 14 Mario Ojeda Mathilde Hunault 15 Anne Banos 16 Bruno Lioure 17 Marc Bernard 18, 19 Eric Jourdan 20 Norbert Vey 21 Hacène Zerazhi 22 Hichri Yosr Roselyne Delépine 3 Rachid Salmi 23 François Dreyfus 24 Jean-Yves Cahn 25 Norbert Ifrah 26
Abstract : no abstract
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01295674
Contributor : Laurent Jonchère <>
Submitted on : Thursday, March 31, 2016 - 2:17:25 PM
Last modification on : Thursday, November 19, 2020 - 3:56:08 PM

Identifiers

  • HAL Id : hal-01295674, version 1

Citation

Arnaud Pigneux, Christian Récher, Marie C. Bene, Julien Asselineau, Ariane C. Mineur, et al.. Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial. Blood, American Society of Hematology, 2015, 126 (23). ⟨hal-01295674⟩

Share

Metrics

Record views

828